Skip to content

Oncology SupportOncology Support

This collection holds anticancer and supportive-care medicines, including Nolvadex, Methotrexate Tablets and Zofran. It spans hormone therapy, cytotoxic treatment and targeted small molecules used against specific cancers.

Synthroid

Levothyroxine

25mcg · 50mcg · 75mcg · 100mcg · 125mcg · 150mcg · 200mcg

Levothyroxine tablets for hypothyroidism. They replace the thyroid hormone that your own thyroid is not producing.

From$0.13/ tabletView

Levothroid

Levothyroxine

25mcg · 50mcg · 75mcg · 100mcg · 112mcg · 125mcg · 200mcg

Levothyroxine tablets for hypothyroidism and to suppress thyroid-stimulating hormone. They replace the missing thyroid hormone.

From$0.24/ tabletView

Methotrexate Tablets

Methotrexate

2.5mg · 5mg · 7.5mg · 10mg

Methotrexate tablets for rheumatoid arthritis and psoriasis. It calms the immune system's attack on joints and skin.

From$0.41/ tabletView

Zofran

Ondansetron

4mg · 8mg

Ondansetron tablets for nausea and vomiting after chemotherapy or surgery. It blocks a chemical that triggers the vomiting reflex.

From$0.56/ tabletView

Nolvadex

Tamoxifen

10mg · 20mg

Tamoxifen tablets for breast cancer. It blocks oestrogen from attaching to hormone-sensitive breast cancer cells.

From$0.67/ tabletView

Zyloprim

Allopurinol

100mg · 300mg

Allopurinol tablets for gout and high uric acid. It reduces the amount of uric acid the body makes, helping to prevent flare-ups.

From$0.57/ tabletView

Efudex

Fluorouracil

5%

Fluorouracil cream for actinic keratosis and some skin cancers. It destroys precancerous and cancerous cells by blocking their rapid division.

From$36.40/ tubeView

Evista

Raloxifene

60mg

Raloxifene tablets for postmenopausal osteoporosis and breast cancer. It mimics oestrogen in bone but opposes it in breast tissue.

From$0.80/ tabletView

Altraz

Anastrozole

1mg

Anastrozole tablets for breast cancer. It blocks the aromatase enzyme, cutting off the oestrogen supply that certain tumours depend on.

From$3.92/ tabletView

Aromasin

Exemestane

25mg

Exemestane tablets for breast cancer. It lowers oestrogen levels in postmenopausal women by permanently blocking the aromatase enzyme.

From$3.56/ tabletView

Casodex

Bicalutamide

50mg

Bicalutamide tablets for prostate cancer. It blocks the effect of testosterone on cancer cells and is usually taken alongside another hormone treatment.

From$8.13/ tabletView

Gleevec

Imatinib

400mg

Imatinib tablets for chronic myeloid leukaemia and stomach tumours. It disables the abnormal protein that fuels the growth of leukaemia cells.

From$10.63/ tabletView

Cytoxan

Cyclophosphamide

50mg

Cyclophosphamide tablets for malignant lymphomas and multiple myeloma. It damages the DNA of cancer cells to stop them from multiplying.

From$1.76/ tabletView

Zocitab

Capecitabine

500mg

Capecitabine tablets for metastatic breast and colorectal cancer. The body converts it into the active chemotherapy agent inside the tumour.

From$13.62/ tabletView

Hydrea

Hydroxycarbamide

500mg

Hydroxycarbamide tablets for chronic myeloid leukaemia and certain head and neck cancers. It works by stopping cancer cells from dividing.

From$2.12/ tabletView

Purinethol

Mercaptopurine

50mg

Mercaptopurine tablets for acute lymphoblastic leukaemia. They interfere with the DNA building blocks in cancer cells.

From$0.70/ tabletView

Eulexin

Flutamide

250mg

Flutamide capsules for prostate cancer. They block male hormones from reaching prostate tissue.

From$2.29/ capsuleView

Alkeran

Melphalan

2mg

Melphalan tablets for multiple myeloma and ovarian carcinoma. As an alkylating agent, it damages the DNA of cancer cells to stop them dividing.

From$4.56/ tabletView

Leukeran

Chlorambucil

2mg

Chlorambucil tablets for chronic lymphocytic leukaemia and Hodgkin lymphoma. It damages the DNA inside cancer cells so they die off.

From$5.01/ tabletView

Kytril

Granisetron

1mg · 2mg

Granisetron tablets for nausea and vomiting caused by chemotherapy or radiotherapy. It blocks the body's nausea trigger in the gut and brain.

From$3.22/ tabletView

Thalix

Thalidomide

50mg

Thalidomide capsules for multiple myeloma and erythema nodosum leprosum. It influences the immune system and blood vessel growth.

From$2.98/ capsuleView

Nexavar

Sorafenib

200mg

Sorafenib tablets for liver and kidney cancer. It blocks the growth of new blood vessels that tumours need to grow.

From$5.24/ tabletView

Sprycel

Dasatinib

50mg

Dasatinib tablets for chronic myeloid and acute lymphocytic leukaemia. It blocks proteins that drive leukaemia cell growth.

From$129.00/ bottleView

Afinitor

Everolimus

5mg

Everolimus tablets for renal cell carcinoma and breast cancer. It blocks mTOR, a protein that controls cell growth and blood vessel formation in tumours.

From$43.64/ tabletView

Ibrutinib Capsules

Ibrutinib

140mg

Ibrutinib capsules for mantle cell lymphoma and chronic lymphocytic leukaemia. A targeted cancer medicine that blocks a specific protein driving the cancer.

From$23.83/ capsuleView

Kisqali

Ribociclib

200mg

Ribociclib tablets for breast cancer. It blocks the signals that tell cancer cells to divide, slowing their spread.

From$93.60/ tabletView

Lenalidomide Capsules

Lenalidomide

10mg

Lenalidomide capsules for multiple myeloma and myelodysplastic syndromes. It is a thalidomide analogue that alters the immune system to attack cancer cells.

From$20.03/ capsuleView

Pomalyst

Pomalidomide

4mg

Pomalidomide capsules for multiple myeloma. This is a newer generation of a drug class that works with the immune system to target myeloma cells.

From$63.90/ capsuleView

Tarceva

Erlotinib

100mg

Erlotinib tablets for non-small cell lung and pancreatic cancer. It targets a protein that helps these cancers grow.

From$16.27/ tabletView

Key points

  • Cancer medicine identity depends on the cancer type, stage, biomarkers and the treatment role a medicine plays, not on one shared label.
  • Targeted therapies act on specific proteins or pathways involved in how cancer cells grow and spread.
  • Supportive-care medicines manage treatment effects, such as nausea, or related complications, rather than acting directly on a tumour.

Hormone therapy, cytotoxic medicines and targeted therapy

Hormone-related medicines lead one part of this range, including Tamoxifen (Nolvadex) and anastrozole tablets (Altraz), used for Breast Cancer. Conventional cytotoxic medicines such as capecitabine (Zocitab) and cyclophosphamide (Cytoxan) sit alongside newer targeted small molecules, including imatinib (Gleevec) for chronic myeloid leukaemia, sorafenib (Nexavar) for kidney and thyroid cancers, and Ribociclib medicines.

Supportive care medicines in this collection

Zofran and Kytril contain ondansetron and granisetron, used for nausea and vomiting linked to cancer treatment. Zyloprim, prescribed for hyperuricaemia, is attached to this collection through a similar cancer-therapy link rather than an anticancer role of its own.

Further reading